AbbVie today announced the availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the treatment of platinum-resistant high grade serous epithelial ovarian cancer, fallopian tube or ...
Hosted on MSN
Peritoneal Cancer: A Rare Abdominal Cancer
Peritoneal cancer, also called primary peritoneal cancer, is a rare type of cancer, occurring in fewer than seven out of every million people in the United States. The peritoneum is a membrane that ...
The FDA granted NXP800 orphan drug designation (ODD) for the potential treatment of patients with AT-rich interactive domain-containing protein 1a (ARID1a)-deficient ovarian, fallopian tube, and ...
SB221: A proof-of-concept study to assess the combination of SON-1010 (IL12-FHAB) and atezolizumab in patients with platinum-resistant ovarian cancer. This is an ASCO Meeting Abstract from the 2024 ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive Keytruda. The U.S. Food and Drug Administration (FDA) has approved PD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results